A desperate late-night decision by a teenage boy in Alabama has turned into a nationwide story of urgency, resilience, and the complicated reality of accessing experimental cancer treatments.
Will Roberts, 15, has spent the past 16 months fighting osteosarcoma, a rare and aggressive form of bone cancer that primarily affects children and young adults. Despite undergoing chemotherapy, his condition has continued to progress, pushing his family to search for alternatives beyond standard care.
Osteosarcoma is known for its intensity and limited treatment options once it reaches advanced stages. According to the National Cancer Institute, survival rates drop significantly when the disease spreads, often forcing families to explore clinical trials or experimental therapies.
In April, without telling his mother, Will recorded and posted a video to her Facebook account. In it, he asked viewers to share his story widely, hoping it might reach someone who could help. His message was simple but urgent: his family had identified a promising experimental drug called DeltaRex-G, but accessing it in time was the challenge.
“I want my life, just as anybody does,” he said in the video, which quickly spread across social media.
DeltaRex-G is a targeted gene therapy still under investigation. Early research suggests it may offer extended survival in certain hard-to-treat cancers. A study referenced by the U.S. National Library of Medicine has documented cases where patients with advanced malignancies experienced longer-term survival, though experts caution that such treatments remain experimental and are not yet widely approved.
Within days, Will’s video had been viewed millions of times. The attention reached political and business circles, eventually making its way to President Donald Trump through intermediaries. Reports indicate that members of his circle, along with other public officials, became aware of the teenager’s plea.
The surge in attention helped connect Will’s family with specialists, including a treatment center in California that offers access to the experimental therapy. The plan involves multiple weekly sessions, but the cost is staggering, estimated at around $500,000.
Financial barriers like this are not uncommon in experimental care. According to the American Cancer Society, patients seeking cutting-edge or investigational treatments often face significant out-of-pocket expenses, especially when therapies are not yet covered by insurance.
To manage the cost, the Roberts family launched a public fundraiser. Contributions quickly exceeded expectations, reflecting the emotional impact of Will’s story and the broader concern about access to life-saving care.
Yet beyond his own fight, Will has expressed a larger goal. He hopes his experience will bring attention to the challenges families face when trying to access promising treatments, particularly for children with rare cancers.
“I may not survive,” he said in an interview. “But if I can help other kids get these treatments without going through all this, then it means something.”
While breakthroughs in cancer research continue, getting those treatments to patients quickly and affordably remains a major hurdle.
For now, Will’s journey continues, supported by a global audience that began with a single, quiet post made in hope.
